Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice

Fig. 2

Effects of dapagliflozin administration on metabolic parameters in lean and ob/ob mice. Effects of dapagliflozin on blood glucose levels and weight trend analysis after treatment. After 30 days of treatment, a significant reduction of blood glucose plasma levels was observed in both lean and ob/ob animals treated with dapagliflozin. Body weight reduction was reported in both lean and ob/ob mice; however, the statistical significance was observed only in the treated lean group

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us